Corporate Governance

Responsibilities of the Directors

Advanced Oncotherapy plc is subject to the City Code on Takeovers and Mergers and the Directors acknowledge the importance of the Combined Code on Corporate Governance. Their intention is to comply with its principles and provisions insofar as it is practicable for a company of its size and in regard to the industry sector of medical devices.

The Board of Directors meets monthly to review key operational issues, strategic development and the financial performance of the Company. The Board undertakes to represent the intentions of shareholders, investors and key stakeholders. The Board is responsible for internal controls to minimise the risk of financial or operational loss or material misstatement. The list of matters reserved to the Board is available here

Composition of the Board of Directors

The composition of the board is designed to ensure Advanced Oncotherapy has robust and relevant experience from a technology and commercial perspective for a medical device company. The Directors' backgrounds and experiences cover areas of commercial and business development, financial management and control. The full composition of the Board is available here.

Board Committees

The following committees have been established to deal with specific aspects of the Company's affairs, in addition to the usual internal control procedures to govern its routine business activities.

Remuneration Committee

Chairman: Hans von Celsing
Members: Michael Bradfield, Enrico Vanni
Terms of Reference

Audit Committee

Chairman: Hans von Celsing
Members: Michael Bradfield, Enrico Vanni
Terms of Reference